Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer

Figure 6

Validation of the predictive efficacy of the Signature in external data GSE13507: (a) shows the classification of the high-risk groups and the low-risk groups with 5-year survival as the boundary, together with the scores and numbers of each group. (b) shows the relationship between survival time, survival events, and grouping. (c) shows the expression levels of four macrophage phagocytosis regulatory factors in relation to grouping. (d) shows the validation of the Signature in the external data set, which was found to have equally high prognostic value in predicting 5-year survival. (e) shows the validation of the signature in an external data set for the prediction of 5-year survival of tumor patients.

(a)

(b)

(c)

(d)

(e)